Applicability of the 3-Strata ESC/ERS risk model at baseline in pulmonary veno-occlusive disease

26 August 2023 (16:15 - 17:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Alejandro Cruz Utrilla

12th of October University Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail

Comprehensive risk assessment in patients with pulmonary arterial hypertension referred for lung transplantation: a single-center experience

Doctor S. Ishii (Tokyo, JP)

Abstract Slides Video

Presentation thumbnail

Impact of triple vasodilator therapy on prognosis stratification of pulmonary arterial hypertension associated with congenital heart disease

Doctor R. Luna (Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

REVEAL Score performance in patients with WHO Group 2 pulmonary hypertension

Doctor D. Sharp Dimitri (Cincinnati, US)

Abstract Slides Video

Presentation thumbnail

Analysis of prognostic predictors and differences between subgroups of pulmonary arterial hypertension associated with portal hypertension and HIV infection

Doctor R. Bertozzi (Cesena, IT)

Abstract Slides Video

Presentation thumbnail

Phenotype and outcome correlates of high dose loop diuretics in type 1 pulmonary hypertension

Doctor D. Barbisan (Treviso, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Risk assessment in pulmonary hypertension: still a hot topic

The Event

Event poster

ESC Congress 2023

26 August 2023 16:15 CET

You may be interested in

Congress Presentation

A single echocardiographic or hemodynamic parameter improves risk stratification in prevalent patients with pulmonary arterial hypertension

Congress Session

Phenotyping and risk stratification in pulmonary arterial hypertension

Congress Session

Pulmonary hypertension: evolving strategies in diagnosis and management

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources